Ingevity Corporation NGVT
$68.25
-$1.16-1.67%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -1.38% | 6.30% | -2.71% | -10.14% | -17.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.38% | 6.30% | -2.71% | -10.14% | -17.19% |
| Cost of Revenue | -2.26% | 13.96% | -3.13% | -19.47% | -28.61% |
| Gross Profit | -0.08% | -3.60% | -2.06% | 8.01% | 8.13% |
| SG&A Expenses | 2.35% | 11.55% | 8.56% | 2.82% | -2.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.30% | 13.57% | -0.59% | -15.33% | -24.24% |
| Operating Income | -1.63% | -12.68% | -9.38% | 11.22% | 15.91% |
| Income Before Tax | 280.86% | -382.26% | -1.14% | 96.01% | 93.86% |
| Income Tax Expenses | -48.15% | 22.64% | 142.93% | 164.47% | 140.23% |
| Earnings from Continuing Operations | 155.75% | -329.75% | -23.81% | 79.87% | 83.86% |
| Earnings from Discontinued Operations | 116.80% | 116.96% | 89.35% | 90.95% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.93% | 63.88% | 61.17% | 88.31% | 49.78% |
| EBIT | -1.63% | -12.68% | -9.38% | 11.22% | 15.91% |
| EBITDA | -2.59% | -10.46% | -8.13% | 4.17% | 6.15% |
| EPS Basic | 125.94% | 64.13% | 60.95% | 88.43% | 50.00% |
| Normalized Basic EPS | -42.21% | -53.72% | -51.47% | 110.01% | 120.09% |
| EPS Diluted | 124.63% | 63.48% | 60.62% | 88.22% | 50.07% |
| Normalized Diluted EPS | -43.13% | -54.23% | -51.84% | 109.49% | 120.09% |
| Average Basic Shares Outstanding | -2.44% | -1.12% | -0.26% | 0.25% | 0.36% |
| Average Diluted Shares Outstanding | -1.36% | -0.44% | 0.27% | 0.79% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |